Suggestions(1)
Exact(3)
Just what Chen needed, a nice easy, event free inning.
Stage III FH patients had a 4-year event free survival of 84%.
Anyone not experiencing the 'event' (i.e. event free) is considered censored.
Similar(57)
Secondary end points included event-free survival and restenosis.
He had event-free survival for nearly 7 years.
The primary outcome was 3-year event-free survival (EFS).
Event-free survival was similar across the different centers.
MBF and MFR both have predictive values of cardiovascular event-free survival [15, 16].
The 3-year event-free survival (EFS) is 38%45%5% for HL; 30% NHL).
Importantly, our patients without CAD had a 100% event-free survival at mid-term follow-up.
OS and event-free survival are frequent primary endpoints in phase 3 trials.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com